ORIGINAL RESEARCH
Published on 12 Feb 2026
Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study
doi 10.3389/fimmu.2026.1714533
- 509 views
- 1 citation
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Advancing Next-Generation Immunotherapy and Biomarker Discovery: Pioneering the Future of Treatment Strategies in Solid Tumors
Advancing Next-Generation Immunotherapy and Biomarker Discovery: Pioneering the Future of Treatment Strategies in Solid Tumors
1,200
Total downloads
13k
Total views and downloads
Articles
REVIEW
Published on 12 Jan 2026
Terminally exhausted CD8+ T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology
doi 10.3389/fimmu.2025.1709852
- 2,332 views
- 3 citations
CASE REPORT
Published on 08 Jan 2026
Case Report: Multimodal immunotherapeutic regimen (envafolimab + chemotherapy + radiotherapy) for four synchronous primary malignant neoplasms: a case report of 33-month survival and implications for tumor immunology
doi 10.3389/fonc.2025.1727323
- 605 views
CLINICAL TRIAL
Published on 12 Dec 2025
Intratumoral delivery of PD-1/PD-L1 and CTLA-4 inhibitors for recurrent/refractory solid tumors: a proof-of-concept treatment strategy
doi 10.3389/fimmu.2025.1669924
- 1,921 views
- 1 citation
ORIGINAL RESEARCH
Published on 05 Nov 2025
Early C-reactive protein reduction predicts survival in real-world extensive-stage small cell lung cancer treated with first-line adebrelimab-based immunotherapy
doi 10.3389/fonc.2025.1709336
- 1,378 views
ORIGINAL RESEARCH
Published on 09 Oct 2025
Blood-derived ratio indexes associated with severity and prognosis of immune checkpoint inhibitor-related cardiotoxicity: a retrospective analysis
doi 10.3389/fonc.2025.1676806
- 1,593 views
ORIGINAL RESEARCH
Published on 18 Sep 2025
Preliminary study on BRICS sequential therapeutic regimen as salvage treatment for refractory advanced colorectal cancer patients harboring pMMR status
doi 10.3389/fimmu.2025.1670812
- 1,890 views
- 1 citation
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore